Columbia Sportswear Company Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered board elections, auditor ratification, executive compensation, and a failed proxy access proposal. 2025 saw modest sales growth, margin pressure, and strategic initiatives targeting younger consumers, with strong cash returns to shareholders.
-
Net sales and profitability exceeded guidance, with international growth offsetting U.S. declines. Gross margin contracted slightly due to tariffs, but strong order books and marketing momentum support a positive outlook, despite ongoing risks from tariffs and geopolitical events.
Fiscal Year 2025
-
Q4 2025 results exceeded guidance with strong international growth offsetting U.S. softness. Gross margin expanded despite tariff headwinds, and 2026 guidance calls for 1%-3% sales growth and operating margin improvement, with U.S. wholesale expected to rebound in the second half.
-
International growth offset U.S. softness, with net sales up 1% and strong performance in Europe and China. Tariffs and higher SG&A pressured margins, but new products and marketing are driving brand momentum. Full-year sales are expected flat to down 1%.
-
Second quarter net sales rose 6% year-over-year, driven by strong international growth, while U.S. sales declined amid tariff and consumer headwinds. Full-year guidance was lowered, reflecting U.S. softness, but international momentum and cost savings continue to support results.
-
Q1 net sales and earnings exceeded guidance, led by strong international growth and resilient wholesale demand. The company faces significant U.S. tariff uncertainty, expects $40–$45 million in incremental costs in 2025, and has withdrawn full-year guidance while maintaining a healthy balance sheet and pursuing cost savings.
Fiscal Year 2024
-
International and DTC growth offset North American softness in 2024, with Q4 sales up 3% and gross margin expanding. 2025 guidance calls for 1%-3% sales growth, higher marketing spend, and further cost reviews, with China and Europe leading growth.
-
Q3 net sales fell 5% year-over-year, with North America soft but strong growth in China and Europe. Gross margin expanded to 50.2%, and EPS exceeded guidance. 2024 outlook was lowered for sales but raised for EPS, with a new $600M buyback and the ACCELERATE strategy launched.
-
Q2 sales declined 8% year-over-year, with U.S. weakness offset by strong international growth, especially in China and Europe. Inventory was reduced by 29%, and full-year guidance was reiterated, with expectations for sequential improvement and a return to growth in 2025.